Resources
Team members
Malak Zeineldin
Mahmoud Tarek
Background
Our research team is investigating the complex interactions between sickle cells and blood vessels to better understand the mechanisms underlying thrombosis in sickle cell disease (SCD). By using advanced simulation techniques, we aim to create virtual models of the circulatory system and study how sickle cells contribute to clot formation. Our research has the potential to identify new risk factors for thrombosis and inform the development of more effective prevention and treatment strategies for SCD patients.
Impact
Objective: To develop a comprehensive understanding of the mechanisms underlying thrombosis in sickle cell disease (SCD) through advanced computer simulations, leading to improved prevention and treatment strategies.
Expected Impact:
Enhanced Understanding of Thrombosis: Our research will provide valuable insights into the complex interactions between sickle cells and blood vessels, contributing to a deeper understanding of the mechanisms underlying thrombosis in SCD.
Identification of High-Risk Individuals: By studying the factors that contribute to clot formation in simulated environments, we may be able to identify individuals at high risk for thrombosis, allowing for early intervention and prevention.
Development of Novel Therapies: Our findings could inform the development of new therapeutic strategies to prevent or treat thrombosis in SCD patients, potentially improving their quality of life and reducing the burden of the disease.
Advancement of Medical Research: Our research will contribute to the advancement of medical knowledge and technology, paving the way for future innovations in the field of SCD.
Societal Benefits: By improving the lives of individuals with SCD and reducing the healthcare burden associated with the disease, our research will have a positive impact on society.
Key Metrics:
Accuracy of the simulation models in predicting the behavior of sickle cells and blood vessels.
Identification of novel risk factors for thrombosis in SCD patients.
Development of new therapeutic targets or strategies based on simulation results.
Publication of research findings in peer-reviewed journals.
Adoption of research findings by the medical community.
Dissemination and Implementation:
Publication of research findings in high-impact scientific journals.
Collaboration with medical researchers, clinicians, and pharmaceutical companies to translate our findings into clinical practice.
Development of educational materials for healthcare providers and patients.
Participation in conferences and workshops to disseminate our research findings.
By achieving these objectives and impacts, our research will make a significant contribution to the field of SCD and improve the lives of individuals affected by this debilitating disease.